*Dianthus Therapeutics Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis Ongoing; Top-Line Results on Track for 2H'25 >DNTH

Dow Jones · 03/11 20:02

Please log in to view news